Although Deniz et al. suggested that higher BMI, higher glucose levels or hyperinsulinemia may be the result of reduced NUCB2/Nesfatin-1 in PCOS, it is unclear how NUCB2/Nesfatin-1 levels decrease in PCOS patients (1). The gene discussed is NUCB2; the disease is hyperinsulinism.